ResMed | RMD - Les Charges D'Exploitation





Les Charges D'Exploitation Changement Date
Ansell USD 880.1M 465.65M 2025-12
Artivion USD 111.2M 9.45M 2025-12
AtriCure USD 143.94M 3.22M 2026-06
Baxter International USD 2.68B 3.36B 2026-06
Cochlear AUD 914.9M 454.8M 2025-12
Cooper Companies USD 844.2M 268.3M 2026-06
CSL USD 5.7B 2.82B 2025-12
Dexcom USD 990.1M 53.5M 2026-06
Edwards Lifesciences USD 1.22B 87.6M 2026-06
Fisher Paykel Healthcare NZD 869.6M 67.2M 2026-06
Globus Medical USD 835.58M 239.73M 2026-06
Haemonetics USD 145.34M 148.66M 2026-06
Idexx Laboratories USD 791.02M 12.78M 2026-06
Inogen USD 49.14M 665K 2024-09
Insulet USD 672M 32.3M 2026-06
Integra LifeSciences USD 1.04B 971K 2026-06
Intuitive Surgical USD 1.91B 3.6M 2026-06
Medtronic USD 7.92B 203M 2026-06
Philips EUR 3.75B 147M 2026-06
Ramsay Health Care AUD 8.8B 83.5M 2025-12
ResMed USD 1.01B 83.57M 2026-06
Sigma Healthcare AUD 1.68B 174.89M 2024-12
Sonic Healthcare AUD 4.23B 2.14B 2024-12
Steris USD 1.21B 62.8M 2026-06
Teleflex USD 2.9B 179.9M 2026-06
Thermo Fisher Scientific USD 9.81B 716M 2026-06